Keymed Biosciences Inc (2162)

Hong Kong

Currency in HKD

2162 Pro Research

64.05

+1.20(+1.91%)

Closed·26/06

Fair Value

Unlock Value

Day's Range

61.90

66.80

52 wk Range

44.45

81.85

2162 Income Statement

Featured here, the Income Statement (earnings report) for Keymed Biosciences Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

428.12

716.31

Total Revenues Growth

aa.aa

+20.91%

+67.31%

Cost Of Revenues

aa.aa

12.2

89.26

Gross Profit

aa.aa

415.92

627.06

Gross Profit Growth

aa.aa

+31.12%

+50.76%

Gross Profit Margin %

aa.aa

97.15%

87.54%

Other Operating Expenses, Total

aa.aa

1,042.01

1,258.11

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+34.51%	+20.74%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	735.19	723.53
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	298.83	504.8
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.99	29.78

Operating Income

aa.aa

-626.09

-631.05

Operating Income Growth

aa.aa

-36.87%

-0.79%

EBIT Margin %

aa.aa

-146.24%

-88.1%

Net Interest Expenses

aa.aa

69.87

53.28

Net Interest Expenses Growth

aa.aa

-1.71%

-23.75%

Interest Expense, Total

aa.aa

-18.46

-16.91

Interest And Investment Income

aa.aa

88.33

70.19

Other Non Operating Expenses, Total

aa.aa

47.51

26.18

EBT, Excl. Unusual Items

aa.aa

-508.71

-551.59

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-508.65

-520.72

EBT, Incl. Unusual Items Growth

aa.aa

-42.8%

-2.37%

EBT, Incl. Unusual Items Margin

aa.aa

-118.81%

-72.69%

Income Tax Expense

aa.aa

6.26

1.87

Net Income to Company

aa.aa

-514.91

-522.6

Minority Interest

aa.aa

-0.33

-0.04

Net Income

aa.aa

-515.24

-522.64

Net Income Growth

aa.aa

-43.38%

-1.44%

Net Income Margin %

aa.aa

-120.35%

-72.96%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-515.24

-522.64

Basic EPS - Continuing Operations

aa.aa

-1.97

-1.91

Basic EPS - Continuing Operations Growth

aa.aa

-43.06%

+3.02%

Diluted EPS - Continuing Operations

aa.aa

-1.97

-1.91

Diluted EPS - Continuing Operations Growth

aa.aa

-43.06%

+3.02%

Basic Weighted Average Shares Outstanding

aa.aa

261.95

273.98

Diluted Weighted Average Shares Outstanding

aa.aa

261.95

273.98

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-551.07

-549.27

EBITDA Growth

aa.aa

-35.8%

+0.33%

EBITDA Margin %

aa.aa

-128.72%

-76.68%

EBIT

aa.aa

-626.09

-631.05

* In Millions of CNY (except for per share items)

FAQ

What was Keymed Biosciences’s revenue at year end?

At the end of the last reported fiscal year, Keymed Biosciences (2162) recorded total revenue of 716.31 million CNY.

How much revenue did Keymed Biosciences report in the most recent quarter?

In its most recent quarterly earnings report, Keymed Biosciences posted revenue of 217.56 million CNY.

What was Keymed Biosciences’s net income for the year?

For the full year, Keymed Biosciences reported net income of -522.64 million CNY.

How much net income did Keymed Biosciences post in the last quarter?

In the most recent quarter, Keymed Biosciences (2162) posted net income of -443.80 million CNY.

What was Keymed Biosciences’s gross profit for the year?

Gross profit for the year was reported at 627.06 million CNY.

How much gross profit did Keymed Biosciences generate last quarter?

Keymed Biosciences recorded gross profit of 161.78 million CNY in its latest quarterly report.

What was Keymed Biosciences’s annual operating income?

For the full year, Keymed Biosciences (2162) reported operating income of -631.05 million CNY.

What was Keymed Biosciences’s operating income last quarter?

Quarterly operating income was -496.72 million CNY.

What was Keymed Biosciences’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -455.31 million CNY.

What was the quarter-over-quarter change in EBITDA for Keymed Biosciences?

EBITDA changed by -384.61% million CNY compared to the last quarter.

How did Keymed Biosciences’s revenue change compared to the previous quarter?

Revenue changed by -56.38% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Keymed Biosciences?

In the latest quarter, gross profit changed by -65.23% million CNY from the previous quarter.

PSEi Composite

6,072.24

+1.18

+0.02%

Nikkei 225

69,360.88

-3,005.46

-4.15%

Shanghai

4,027.26

-93.02

-2.26%

US 500

7,333.20

-24.8

-0.34%

US Tech 100

28,989.90

-450.4

-1.53%

DAX

24,671.22

-323.61

-1.29%

Dollar Index

101.13

-0.070

-0.07%

Market Movers

Name	Last	Chg. %	Vol.
Maynilad Water Services	19.88	-1.83%	12.42M
BDO Unibank	121.00	-0.82%	4.77M
Puregold Price Club	40.300	-2.07%	3.98M
International Container	885.000	-1.12%	1.71M
Ayala Pref	422.20	+1.49%	589.73K
Ayala	422.20	+1.49%	589.73K
SM Investments	596.50	+0.08%	281.67K

Name	Last	Chg. %	Vol.
ABS-CBN Holdings	1.65	+19.57%	86.00K
Prime Media	0.800	+14.29%	3.00K
DoubleDragon	12.680	+11.23%	2.91M
Makati Finance	2.190	+10.61%	3.00K
Manila Broadcasting Co	5.520	+10.40%	1.40K
ABS CBN	1.940	+8.99%	403.00K
Philippine Estates	0.445	+8.54%	190.00K

Name	Last	Chg. %	Vol.
Vivant	18.580	-10.46%	100.00
Manila Bulletin	0.188	-9.62%	20.00K
Metro Alliance Holdings Equities	1.09	-9.17%	34.00K
Boulevard	0.0330	-8.33%	24.90M
Philcomsat Holdings	1.63	-7.91%	2.00K
Nickel Asia	3.6300	-7.40%	13.57M
LFM Properties	0.03	-6.06%	100.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Synergy Grid	29.90	+4.55%	4.13M
Jollibee Foods	131.50	-2.59%	899.12K
Wilcon Depot	5.490	-1.44%	458.30K
Ayala Land	15.300	+1.19%	10.28M
PLDT	1,128.00	-1.57%	139.62K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	1.900	+49.72%	2.845
Aaa A A A	33.700	+47.38%	49.667
Aaaaaa	2.050	+41.87%	2.908
Aaaaaaaaaaaaaaaa A	26.300	+41.17%	37.128
Aaaaaaaa	262.000	+38.51%	362.896
Aa A Aaaaaaaaaa	12.400	+36.24%	16.894
Aaaaaaaaa	15.300	+35.31%	20.702

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	1.900	+49.72%	2.845
Aaa A A A	33.700	+47.38%	49.667
Aaaaaa	2.050	+41.87%	2.908
Aaaaaaaaaaaaaaaa A	26.300	+41.17%	37.128
Aaaaaaaa	262.000	+38.51%	362.896
Aa A Aaaaaaaaaa	12.400	+36.24%	16.894
Aaaaaaaaa	15.300	+35.31%	20.702

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Keymed Biosciences Inc (2162)

2162 Income Statement

FAQ

What was Keymed Biosciences’s revenue at year end?

How much revenue did Keymed Biosciences report in the most recent quarter?

What was Keymed Biosciences’s net income for the year?

How much net income did Keymed Biosciences post in the last quarter?

What was Keymed Biosciences’s gross profit for the year?

How much gross profit did Keymed Biosciences generate last quarter?

What was Keymed Biosciences’s annual operating income?

What was Keymed Biosciences’s operating income last quarter?

What was Keymed Biosciences’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Keymed Biosciences?

How did Keymed Biosciences’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Keymed Biosciences?

Trending Stocks